AUP Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$351,471.75
Insider Selling (Last 12 Months): C$0.00

Aurinia Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Aurinia Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aurinia Pharmaceuticals Share Price & Price History

Current Price: C$16.76
Price Change: Price Decrease of -0.61 (-3.51%)
As of 07/30/2021 09:39 PM ET

This chart shows the closing price history over time for AUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aurinia Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Matthew DonleySenior OfficerBuy10,000C$6.24C$62,444.0026,224
11/9/2022Scott HabigSenior OfficerBuy5,000C$6.67C$33,349.755,000
11/7/2022Michael Robert MartinDirectorBuy30,000C$6.97C$208,980.0055,475
5/18/2022David Roland Walker JayneDirectorBuy10,000C$4.67C$46,698.0040,000
11/11/2021Michael Robert MartinDirectorBuy29,000C$28.82C$835,780.0061,824
11/10/2021Neil SolomonsSenior OfficerBuy70,000C$8.00C$559,944.00157,299
11/9/2021Michael Robert MartinDirectorSell50,000C$39.82C$1,991,220.0092,824
10/25/2021Robert HuizingaSenior OfficerBuy95,000C$4.22C$401,280.00195,728
9/21/2021Robert HuizingaSenior OfficerBuy16,000C$3.47C$55,545.60122,092
9/20/2021Michael Robert MartinDirectorBuy28,500C$7.00C$199,386.00171,324
9/13/2021Michael Robert MartinDirectorBuy25,000C$7.01C$175,230.00167,824
9/10/2021Robert HuizingaSenior OfficerSell32,500C$27.92C$907,335.00106,092
9/7/2021Michael Robert MartinDirectorSell7,500C$23.89C$179,190.00142,824
9/7/2021Robert HuizingaSenior OfficerSell5,000C$24.16C$120,780.00138,592
8/26/2021Michael Robert MartinDirectorSell22,500C$23.51C$528,957.00150,324
8/25/2021Neil SolomonsSenior OfficerSell5,000C$20.92C$104,610.00137,299
7/28/2021Michael Robert MartinDirectorSell5,000C$17.41C$87,073.00177,824
6/22/2021Michael Robert MartinDirectorSell5,000C$17.01C$85,050.00182,824
1/28/2021Stephen P. RobertsonSenior OfficerBuy900C$21.30C$19,174.322,720
9/21/2020Chin Kyu HuhInsiderSell48,458C$19.91C$964,988.546,499,881
8/18/2020Robert HuizingaSenior OfficerSell14,000C$19.01C$266,176.40103,592
7/8/2020Neil SolomonsSenior OfficerSell10,000C$21.15C$211,500.00187,299
4/9/2020Neil SolomonsSenior OfficerSell4,100C$21.04C$86,279.17197,299
4/6/2020Neil SolomonsSenior OfficerSell15,000C$21.11C$316,617.00202,299
See Full Table

SEC Filings (Institutional Ownership Changes) for Aurinia Pharmaceuticals (TSE:AUP)

Aurinia Pharmaceuticals logo
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Read More on Aurinia Pharmaceuticals

Today's Range

Now: C$16.76
Low: C$16.41
High: C$17.46

50 Day Range

MA: C$16.76
Low: C$16.76
High: C$16.76

52 Week Range

Now: C$16.76
Low: C$11.77
High: C$26.00


4,611,683 shs

Average Volume

229,895 shs

Market Capitalization

C$2.15 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals' top insider shareholders include:
  1. Robert Huizinga (Senior Officer)
  2. Michael Robert Martin (Director)
  3. Neil Solomons (Senior Officer)
  4. David Roland Walker Jayne (Director)
  5. Matthew Donley (Senior Officer)
  6. Scott Habig (Senior Officer)
Learn More about top insider investors at Aurinia Pharmaceuticals.